Epinephrine Bitartrate

Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 4 USDMF, 5 CEP/COS, 2 JDMF, 2 EU WC, 2 KDMF, 12 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

206 FDF Dossiers, 31 FDA Orange Book, 143 Europe, 31 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.25%;0.0091MG/ML, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML), INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML), INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

4 Kirsch Pharma, 4 Actylis, 2 CD Formulation

EXCIPIENTS BY APPLICATIONS

8 Parenteral, 4 Thickeners and Stabilizers, 1 Taste Masking

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 9 News #PharmaBuzz

GLOBAL SALES INFORMATION

20 Regulatory FDF Prices

20 Regulatory FDF Prices

MARKET PLACE

28 APIs, 3 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 2 JP, 1 Others

$ Xls

Filters

INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML)

INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

INJECTABLE;INJECTION - 0.25%

INJECTABLE;INJECTION - 0.25%;0.0091MG/ML

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - 0.75%

INJECTABLE;INJECTION - 0.75%;0.0091MG/ML

INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML)

INJECTABLE;INJECTION - 0.25%

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - 0.75%

INJECTABLE;INJECTION - 0.75%;0.0091MG/ML

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.